M.I.S. (Laparoscopic Surgery, Robotic Surgery, EMR, ESD) Market – Snapshot 

Minimally invasive surgery (M.I.S.) is a modern technique that enables surgeons to use endoscopic procedures to address diverse issues. The instruments used during minimally invasive surgery (M.I.S.) are small, hence the incisions are smaller than in a traditional open surgery. 

Additionally, the technology is proving its efficiency in treatment while performing complex surgeries thus driving the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market during the forecast period. 

The global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market was valued at US$ 1.1 Bn in 2017 and is projected to expand at a CAGR of 9.2% from 2018 to 2026. The endoscopic mucosal resection segment dominated the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in 2017. 

Multitude of factors including technological advancements driving the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market 

  • Rise in prevalence of chronic diseases, technological advancements, and increase in patient awareness and health care expenditure are driving the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market.
  • Moreover, surge in the need of treatment of complex diseases drive the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market.
  • The robotic surgery segment is expected to be the fastest growing segment of the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market during the forecast period.
  • The segment has witnessed strong growth owing to increase in demand for precise and technological advanced surgery. This in turn is propelling the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market.
  • The highly fragmented nature of the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has prompted market players to shift focus toward relatively niche segments such as robotic surgery. 

Global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) Market: Segmentation Overview

  • The global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been segmented based on procedure, indication, and region.
  • In terms of procedure, the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been classified into laparoscopic surgery, robotic surgery, endoscopic mucosal resection, and endoscopic sub-mucosal dissection.
  • Based on indication, the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been categorized into gastric cancer, Barrett’s esophagus, small intestine (duodenum) cancer, colorectal cancer, esophageal cancer, and others.
  • The colorectal cancer segment is projected to account for major share of the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market due to increase in incidence of targeted diseases across various regions, rise in prevalence of lifestyle diseases, and ongoing technological advancements.
global m i s laparoscopic surgery robotic surgery emr esd market 1

Regional Outlook 

  • In terms of region, North America dominated the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in 2017, owing to a highly developed health care sector, increase in awareness among health care providers about minimally invasive surgery, and continuous evolution of products.
  • North America is also an attractive market in terms of revenue. Rise in government initiatives & laws and increase in population drive the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in the region.
  • Technological advancements and increase in adoption of advanced surgery devices are expected to propel the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.
m i s laparoscopic surgery robotic surgery emr esd market

Competitive Overview 

Key players operating in the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market include,

  • University of Pittsburgh Medical Center
  • Rutland Medical Center
  • Huntington Hospital
  • Washington Hospital Healthcare System
  • The Ottawa Hospital
  • Michael's Hospital
  • Charité - Universitätsmedizin Berlin
  • Ipswich Hospital
  • Apollo Hospitals Enterprise Limited
  • HealthCare Global Enterprises Ltd. 

The global M.I.S. (Laparoscopic Surgery, Robotic Surgery, EMR, ESD) market has been segmented as follows: 

  • Global M.I.S. (Laparoscopic Surgery, Robotic Surgery, EMR, ESD) Market, by Procedure
    • Laparoscopic Surgery
    • Robotic Surgery
    • Endoscopic Mucosal Resection
    • Endoscopic Sub-mucosal Dissection
  • Global M.I.S. (Laparoscopic Surgery, Robotic Surgery, EMR, ESD) Market, by Indication
    • Gastric Cancer
    • Barrett's Esophagus
    • Small Intestine (duodenum) Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Others
  • Global M.I.S. (Laparoscopic Surgery, Robotic Surgery, EMR, ESD) Market, by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa 

Global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) Market: Overview 

The global minimally invasive surgery (MIS) market is growing at a rapid pace due to increase in use of advanced technology in treating complex diseases. The M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) have wide range of applications in the medical field.The robotic surgery segment is anticipated to expand at a high CAGR during the forecast period, as the procedure has a promising solution for rapid treatment of diseases. Rise in demand for precise and technically advanced devices contributes to the growth of the endoscopic mucosal resection segment in minimally invasive surgery (MIS) market. 

Increase in incidence of chronic diseases drives demand for products that offer rapid and efficient healing. This in turn is driving the minimally invasive surgery (MIS) market. Hence, a majority of hospitals have shifted preference toward advanced procedures. This helps decrease the average length of stay in hospitals through early recovery from disease.

This, in turn, helps reduce surgical costs. Therefore, rise in need and demand for advanced products that increase therapeutic outcome drives the global minimally invasive surgery (MIS) market. 

Global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) Market: Key Segments

  • The global minimally invasive surgery (MIS) market has been segmented based on procedure, indication, and region.
  • In terms of procedure, the minimally invasive surgery (MIS) market has been classified into laparoscopic surgery, robotic surgery, endoscopic mucosal resection, and endoscopic sub-mucosal dissection.
  • Based on indication, the global minimally invasive surgery (MIS) market has been categorized into gastric cancer, Barrett’s esophagus, small intestine (duodenum) cancer, colorectal cancer, esophageal cancer, and others. Each of the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) segments has been analyzed in detail in terms of market trends, recent developments, outlook, and opportunities.
  • The M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) report provides current and future market size for each segments and sub-segments for the period from 2018 to 2026 in terms of revenue (US$ Mn) and volume (no. of procedures), considering 2016 and 2017 as the base years.
  • The compound annual growth rate (% CAGR) for each minimally invasive surgery (MIS) market segment has been provided for the forecast period from 2018 to 2026 along with the estimations of market size.

Global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) Market: Regional Outlook

  • In terms of region, the global minimally invasive surgery (MIS) market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have also been sub-segmented into major countries and sub-regions.
  • The current and future market sizes in terms of revenue (US$ Mn) and volume (no. of procedures) of these regional minimally invasive surgery (MIS) markets and their major countries/sub-regions have been provided in the report for the period from 2016 to 2026, with CAGR (%) for the period from 2018 to 2026.
  • The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares in minimally invasive surgery (MIS) market, which is likely to help in the decision-making process. 

The overview section of the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) report provides the market dynamics and market trends such as drivers, restraints, opportunities, and key trends that influence the current and future status of the market. The minimally invasive surgery (MIS) market report also covers market attractiveness and market share analyses in order to provide a thorough analysis of the overall competitive scenario in the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market. 

Companies Mentioned in Report 

The minimally invasive surgery (MIS) market report concludes with the company profiles section that includes information about the major players in the market. Key players profiled in the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) report include

  • University of Pittsburgh Medical Center
  • Rutland Medical Center
  • Huntington Hospital
  • Washington Hospital Healthcare System
  • The Ottawa Hospital
  • Michael's Hospital
  • Charité - Universitätsmedizin Berlin
  • Ipswich Hospital
  • Apollo Hospitals Enterprise Limited
  • HealthCare Global Enterprises Ltd.

Each of these players has been profiled in the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) report considering parameters such as company overview, financial overview, bussiness strategies, and recent developments. 

The global minimally invasive surgery (MIS) market has been segmented as follows:

Procedure

  • Laparoscopic Surgery
  • Robotic Surgery
  • Endoscopic Mucosal Resection
  • Endoscopic Sub-mucosal Dissection

Indication

  • Gastric Cancer
  • Barrett's Esophagus
  • Small Intestine (duodenum) Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa